leisure time -WSS

leisure time

author：explore 2025-10-02 17:27:36 - browse：4254

A screen at the New York Stock Exchange last November. Michael M. Santiago/Getty Images

Pfizer spent more than four hours Thursday laying out its oncology program to investors. But the company also spent some time talking about the effects of the Inflation Reduction Act on its pipeline.

The drug giant, which is facing investor dissatisfaction after a year in which its stock dropped 44%, said it would be focusing on drugs that are based on proteins, not small molecule pills as it has traditionally developed. (Pfizer’s current best-seller in oncology, Ibrance for breast cancer, is a small molecule pill.) It said the mix of small molecule drugs in its cancer portfolio will drop from 94% last year to 35% in 2030.

That matters because small molecules are more vulnerable to generic competition and the Medicare price negotiation introduced by the IRA. Suneet Varma, the commercial president of Pfizer’s oncology unit, said “this planned shift to biologics is expected to support the accelerated growth in both the top and bottom line,” referring to the revenue and profit lines of a balance sheet.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Virginia high school admissions case could be legal follow
Next article： Juul documents reveal insider tactics on political lobbying

WSS

Amylyx and the next ALS drug test, plus a chat with CRISPR's CEO

Doctors on social media are being harassed and cyberbullied

Long Covid research funding gets a major boost from NIH

Amylyx and the next ALS drug test, plus a chat with CRISPR's CEO

Congress might make insulin pumps more accessible to the blind

STAT Boddities: What happens to the brain when we get scared?

entertainment

leisure time

knowledge

Activists slam private health insurers over coverage restrictions

Francis Collins on trust in science and how Covid communications failed

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Francis Collins on trust in science and how Covid communications failed

In Memoriam: Notable people who died in 2023

Ebola vaccine can save some who are already sick, per new study

Tori Bowie and the unacceptable rates of Black maternal death

Francis Collins on trust in science and how Covid communications failed

Activists slam private health insurers over coverage restrictions

EU regulator recommends expanding Mounjaro approval to obesity

hotspot

My yearlong odyssey to get my son’s ADHD medication covered

Humana cuts profit projections as Medicare Advantage costs soar

What to make of Gilead’s Trodelvy troubles and Elevation Oncology’s rise

How digital therapeutics firms are pivoting after Pear's bankruptcy

Prior authorization will have to move faster under new Biden rule

Medicare Advantage today, explained in one chart

focus

explore

entertainment

leisure time